T6BP Activators
T6BP Activators represent a unique class of chemical agents specifically designed to elevate the functional efficacy of the T6BP protein through intricate biochemical pathways. These activators work by engaging with cellular mechanisms that directly or indirectly support the upregulation of T6BP's activity. A quintessential example is a compound that increases the availability of substrates necessary for T6BP's enzymatic action, thereby enhancing its catalytic potential. Another activator may bind to regulatory regions of the protein, inducing a conformational change that results in an increased affinity for its substrates or partners within the cell, effectively boosting the protein's activity. The mechanisms employed by T6BP activators are diverse, but they converge on a common outcome: the potentiation of T6BP's role within its specific signaling pathways. These activators are meticulously designed to influence the protein's function without altering its expression levels, ensuring that the upregulation of activity is a direct consequence of the activator's interaction with T6BP or its immediate signaling milieu.
The biochemical activation mechanisms of T6BP Activators are multifaceted, requiring a fine-tuned interaction with cellular signaling cascades. Some activators may facilitate the post-translational modifications of T6BP, such as phosphorylation, which are crucial for its activation state. Others might increase the concentration of secondary messengers that act as allosteric modulators of T6BP, thereby modifying its activity. The strategic design of these molecules aims to target specific domains within T6BP or its associated factors, enabling a heightened response to physiological stimuli. This specificity ensures that the activators do not indiscriminately enhance the activity of other proteins, thus maintaining cellular homeostasis. Through these targeted actions, T6BP Activators serve as pivotal modulators of the protein's function, ensuring that its role in cellular processes is not only maintained but augmented to meet the demands of various biological contexts.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), which can then phosphorylate specific substrates that enhance the cellular functions where T6BP is implicated, including inflammatory response regulation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) interacts with S1P receptors, initiating signaling cascades that modulate cellular proliferation, survival, and immune responses. This can indirectly enhance T6BP's role in the regulation of these cellular processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, activating calcium-dependent signaling pathways. Such activation can indirectly enhance the functional activity of T6BP in pathways where calcium signaling is crucial for the modulation of immune responses. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate various signaling pathways, including those that regulate inflammation and apoptosis, where T6BP is known to have a role, thus potentially enhancing its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/Akt pathway. By inhibiting this pathway, LY294002 may enhance the role of T6BP in alternative signaling routes related to the immune response and cellular homeostasis. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which can enhance calcium-mediated signaling pathways where T6BP is involved in the immune response and apoptosis. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which can modulate the MAPK pathway and potentially enhance the role of T6BP in alternative signaling processes related to stress and immune regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK, which can alter the MAPK/ERK pathway and potentially enhance T6BP's function in non-ERK-regulated immune response pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, potentially enhancing T6BP's role in calcium-dependent signaling mechanisms involved in the immune response and cell death regulation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase inhibitor that may enhance T6BP's functional activity by influencing cell cycle regulation and apoptosis pathways where T6BP has a regulatory role. | ||||||